Targeting Bcl-2 protein in treatment of melanoma still requires further clarifications

Ann Oncol. 2008 Dec;19(12):2092-3. doi: 10.1093/annonc/mdn672. Epub 2008 Oct 31.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Humans
  • Melanoma / drug therapy*
  • Melanoma / metabolism*
  • Proto-Oncogene Proteins c-bcl-2 / metabolism*
  • Thionucleotides / pharmacology*

Substances

  • Antineoplastic Agents
  • Proto-Oncogene Proteins c-bcl-2
  • Thionucleotides
  • oblimersen